The Effect of Cinnamon on HbA1c Among Adolescents With Type I Diabetes

This study has been completed.
Sponsor:
Information provided by:
Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier:
NCT00371800
First received: August 31, 2006
Last updated: NA
Last verified: August 2006
History: No changes posted

August 31, 2006
August 31, 2006
October 2005
Not Provided
HbA1c
Same as current
No Changes Posted
  • Total Daily Insulin
  • Carbohydrate/insulin dose
  • Hypoglycemic events
  • Compliance
Same as current
Not Provided
Not Provided
 
The Effect of Cinnamon on HbA1c Among Adolescents With Type I Diabetes
The Effect of Cinnamon on HbA1c Among Adolescents With Type I Diabetes

the purpose of this study is to determine if cinnamon improves glucose control among adolescents with type 1 diabetes mellitus.

Widespread achievement of glucose control remains an elusive goal for adolescents with Type 1 diabetes. Previous research has suggested that cinnamon may be effective at improving glucose control in type 2 diabetes. To date, no research has investigated the effect of cinnamon on type 1 diabetics. If the addition of a simple, natural, pill to a standard insulin regimen can significantly improve glucose control, the clinical implications would be substantial.

Comparison: Using a prospective, double-blind, placebo-controlled design, 72 adolescent type I diabetics were treated with cinnamon (1 gram/day) or an equivalent appearing placebo for 90 days. HbA1c, total daily insulin intake, and adverse events were recorded and compared between groups.

Interventional
Phase 2
Phase 3
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Type 1 Diabetes Mellitus
Drug: cinnamon
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
72
May 2006
Not Provided

Inclusion Criteria:

  1. Diagnosis of Type 1 diabetes for > 18 months prior to enrollment,
  2. Age 13-18 years at the time of enrollment
  3. Presenting to the clinic for routine care,
  4. No hospital admissions for medical or psychiatric reasons in the 12 months prior to enrollment,
  5. Accessible by phone,
  6. Not pregnant.

Exclusion Criteria:

(1) Pregnant

Both
13 Years to 18 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00371800
17648
Not Provided
Not Provided
Dartmouth-Hitchcock Medical Center
Not Provided
Principal Investigator: Samuel J Casella, MD Dartmouth-Hitchcock Medical Center
Dartmouth-Hitchcock Medical Center
August 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP